Phibro Animal Health | PAHC - 债务利息支出

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.29B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	债务利息支出	更改		日
Align Technology	USD 16.04M		14.04M	2025-12
ANI Pharmaceuticals	USD 4.41M		316K	2025-12
Aurora Cannabis	CAD 2.11M		116K	2025-12
Bristol-Myers Squibb	USD 411M		21M	2026-03
Canopy Growth	CAD 7.34M		1.46M	2025-12
Corcept Therapeutics	USD 814.88M		809.46M	2026-03
Eli Lilly	USD 114.7M		134.3M	2025-09
Henry Schein	USD 39M		0	2026-03
Idexx Laboratories	USD 7.74M		2.34M	2026-03
Knight Therapeutics	CAD 3.92M		1.56M	2025-12
Merck	USD 479M		67M	2026-03
Nektar Therapeutics	USD 9.77M		3.75M	2025-12
Pacira	USD 3.7M		193K	2026-03
Phibro Animal Health	USD 11.91M		191K	2025-12
Prestige Brands	USD 10.67M		636K	2025-12
Supernus Pharmaceuticals	USD 910K		278K	2023-06
Zoetis	USD 62M		5M	2026-03